Explore more publications!

The Persian Gulf Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Persian Gulf Newswire.

Press releases published on September 16, 2025

Gauzy Ltd. Provides Update on Board of Directors
Termination of Ruby Graphite Option Agreement
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
Aviation Augmented & Virtual Reality Market Size Expected to Reach $23.6 Billion by 2031
Commitbiz Announces Expansion into Corporate Tax Services Across the UAE
STBL introduces token generation event
Retail Show 2025 Opens Complimentary Visitor Registrations
Terra Clean Energy Corp. Announces Agreement to Earn 100% Interest in 75 Past Producing Uranium Claims on The San Rafael Swell, Utah, United States
AI Academy Launches Region’s First Executive Program for Chief AI Officer
AI Academy Launches Region’s First Executive Program for Chief AI Officer
AI Academy Launches Region’s First Executive Program for Chief AI Officer
أكاديمية الذكاء الاصطناعي تطلق أول برنامج تنفيذي في المنطقة لكبار مسؤلي الذكاء الاصطناعي
أكاديمية الذكاء الاصطناعي تطلق أول برنامج تنفيذي في المنطقة لكبار مسؤلي الذكاء الاصطناعي
أكاديمية الذكاء الاصطناعي تطلق أول برنامج تنفيذي في المنطقة لكبار مسؤلي الذكاء الاصطناعي
Clinichub to Celebrate Patient Journeys with London Appreciation Event on 20 September
Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extremities, Neck and Trunk
West Red Lake Gold Announces Upsize to Previously Announced Bought Deal Public Offering to $36 Million
Silynxcom Secures Order from a Naval Force for Combat-Proven Headset Technology
GoldHaven Resources Completes Summer Exploration Programs at Magno and Three Guardsmen Projects
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions